Sentences with phrase «developing molecular imaging»

For years researchers have been developing molecular imaging techniques that visualize hormonally active breast cancer cells — specifically those testing positive for human epidermal growth factor receptor 2 (HER2).

Scientists are taking medical imaging research and drug discovery to a new level by developing a molecular imaging system that combines several advanced technologies for all - in - one imaging of both tissue models and live subjects, say presenters at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Not exact matches

Xiaoyuan Chen, Ph.D., Chief of the Laboratory of Molecular Imaging and Nanomedicine at NIBIB, and his team attempted to solve this problem by developing a radiotracer that could identify prostate cancer at all stages.

Ralf Jungmann, Ph.D., an alumnus of Harvard's Wyss Institute for Biologically Inspired Engineering and currently a Professor at the Ludwig Maximilian University (LMU) and the Max Planck Institute (MPI) of Biochemistry in Germany and Wyss Institute Core Faculty member Peng Yin, Ph.D., have been developing DNA - PAINT, a powerful molecular imaging technology that involves transient DNA - DNA interactions to accurately localize fluorescent dyes with super-resolution.

The breakthrough came with a new imaging technique, dual - resonance - frequency - enhanced electrostatic force microscopy (DREEM), which was developed by University of North Carolina at Chapel Hill chemist and co-author Dorothy Erie, former UNC and NC State postdoctoral researchers Dong Wu and Parminder Kaur, and was featured earlier this year in Molecular Cell.

For several years, the «Molecular Imaging» research group at the FMP led by physicist Leif Schröder has been developing new MRI methods that rely on just such a «flux compensator» and has demonstrated the impressive potential of this method.

Richards - Kortum's work brings together nanotechnology, molecular imaging, and microfabrication to address global health challenges by developing low - cost medical technologies — such as a portable microendoscope to diagnose and treat cervical cancer — for use on the ground in low - resource settings around the world.

Researchers have developed a fast and practical molecular - scale imaging technique that could let scientists view never - before - seen dynamics of biological processes involved in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

Specifically, the imaging agents developed in the laboratory for use in fluorescence molecular tomography, are now even being translated into the clinic for human diagnostic applications.

One of several applications developed by Automated Molecular Imaging Group at The Scripps Research Institute.

As part of its continuing commitment to growing the practice of nuclear medicine and molecular imaging and therapy worldwide, SNMMI leadership works diligently to develop strategic alliances with key regional nuclear medicine organizations to assist these groups in expanding the scope and quality of nuclear medicine outside the United States.

Finally, the HZI will help develop in vivo imaging technologies to characterize (i) vaccine biodistribution and persistence, and (ii) cellular and molecular changes at the injection site and in draining lymphoid tissues, helping to refine the use of animal models.

Imaging dynamic molecular signaling by the Cdc42 GTPase within the developing CNS.

Abstract: • Imaging method shows nanomaterial forming in real time, for first time • «As close to useful molecular LEGOs as I've seen,» William Dichtel says • Dichtel is a pioneer in developing useful porous polymers

Importantly, the molecular imaging models that are developed can be employed to accelerate the discovery of targets and drugs for therapeutic intervention, and biomarkers that could be used for early diagnosis.

We are developing a broad range of advanced fluorescence - based imaging technologies to assay the functions of the involved molecular machinery non-invasively, automate imaging to address all its molecular components, and computationally process image data to extract biochemical and biophysical parameters.

In the field of nanomedicine, CEA - Léti has developed, over the past 9 years, a growing expertise in molecular optical imaging based on fluorescence imaging, and on nanocarriers for drug delivery.

We have now developed a gentle light - sheet - based microscope for high - throughput imaging of mouse oocytes and embryos to enable systematic molecular analysis of meiosis and early embryonic mitosis (figure 1).

The SNMMI Future Leaders Academy training focuses on setting a clear plan for increasing leadership abilities by developing the necessary skills and organizational expertise to enhance performance and ultimately evolve into a leader both within the nuclear medicine and molecular imaging community and the society.

I am also developing various imaging and molecular sequencing methods for tracking genes, molecules, and cells to understand how cancer cells arise and evolve.

The team will continue to develop and test an imaging - based biomarker that can be used in a clinical setting to enable us to understand the molecular changes to the ganglion cells, so we can detect the disease very early on.